Archives

by in
Entry Author Date Location
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA 02/17/14 National
Myriad Genetics Acquires Crescendo Bioscience for $270M 02/04/14 San Francisco
Myriad Genetics Acquires Crescendo Bioscience for $245,000,000 02/04/14 San Francisco
Cellscape Hunts for Fetal Cells in Mom, Pushing Diagnostic Frontier 08/21/13 San Francisco
Crescendo Bioscience Snags $28M For Arthritis Test 01/03/13 San Francisco
Crescendo Bioscience Garners $28,000,000 Series D Financing Round 01/03/13 San Francisco
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy 09/08/11 San Francisco
Crescendo Bioscience Obtains $25,000,000 New Funding Round 09/08/11 San Francisco
Crescendo Bioscience Secures $31,000,000 Series C Round 09/08/11 San Francisco
Crescendo Bioscience Lands $31,019,775 Series C Financing 06/20/11 San Francisco
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News 02/11/11 San Francisco
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman 02/07/11 San Francisco
Crescendo Bioscience Secures $37,600,004 New Funding 07/07/10 San Francisco
Crescendo Bioscience Lands $5,000,000 Series B Round 11/30/09 San Francisco
Crescendo Bioscience Garners $15,000,000 New Funding 06/30/08 San Francisco
Page 1 of 1